BARKER DAVID L 4

What Happened
David L. Barker, a director of Bionano Genomics (BNGO), received a grant/award of 9,149 shares on 2026-05-14. The award price is $0.00 (no cash paid); total immediate value reported is $0 on the Form 4 because these are restricted/derivative shares subject to vesting rather than an open-market purchase.

Key Details

• Transaction date: 2026-05-14; Transaction type/code: Award/Grant (A) — derivative security.
• Shares granted: 9,149; acquisition price: $0.00; reported value at grant: $0.
• Shares owned after transaction: not specified in the provided filing.
• Vesting/conditions (Footnote F1): Shares vest in equal monthly installments over 12 months, will be fully vested by the company’s next annual meeting if service continues, and vest in full upon a Change of Control. Vesting is subject to the plan’s Continuous Service requirement.
• Filing timeliness: Report filed with Form 4 dated 2026-05-14 (same date as transaction), indicating a timely filing.

Context
This is a compensation-related award typical for directors to align incentives and encourage retention; it is not an outright purchase (which some investors consider a stronger bullish signal). Because the shares vest over time and may forfeit if service ends, the grant primarily reflects company compensation practice rather than immediate insider buying or selling.